Mesa Laboratories, Inc.
MLAB
$107.64
$1.601.51%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -40.32% | 41.86% | 316.59% | -27.77% | 39.96% |
| Total Depreciation and Amortization | -5.24% | -23.30% | 3.97% | -3.61% | 9.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 490.18% | 224.35% | -54.16% | 199.94% | -138.38% |
| Change in Net Operating Assets | 136.79% | -59.45% | 25.85% | 9.31% | -2,252.37% |
| Cash from Operations | 678.45% | 10.24% | 3.45% | 55.99% | -82.38% |
| Capital Expenditure | 44.60% | 44.91% | 9.96% | 38.93% | -13.24% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 44.60% | 58.59% | 9.96% | 38.93% | -13.24% |
| Total Debt Issued | -4.76% | -- | -- | -- | -85.71% |
| Total Debt Repaid | -150.82% | 18.12% | 7.96% | -1,290.84% | 90.82% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 9.71% | -19.62% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.26% | -1.61% | -1.73% | -1.85% | -1.16% |
| Other Financing Activities | -- | 1.75% | -1,170.00% | -83.71% | -834.02% |
| Cash from Financing | -24.58% | 2.68% | 4.88% | 8.44% | 10.53% |
| Foreign Exchange rate Adjustments | -94.14% | -81.44% | 177.07% | -110.48% | 957.71% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 162.35% | 43.69% | 29.22% | 79.27% | -2,441.86% |